- Home
- SGRP vs PPCB Comparison
SGRP vs PPCB Comparison
Compare SGRP & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGRP
- PPCB
- Stock Information
- Founded
- SGRP 1967
- PPCB 2007
- Country
- SGRP United States
- PPCB Australia
- Employees
- SGRP N/A
- PPCB N/A
- Industry
- SGRP Business Services
- PPCB
- Sector
- SGRP Consumer Discretionary
- PPCB
- Exchange
- SGRP Nasdaq
- PPCB Nasdaq
- Market Cap
- SGRP 25.2M
- PPCB 20.4M
- IPO Year
- SGRP 1996
- PPCB N/A
- Fundamental
- Price
- SGRP $1.06
- PPCB $1.49
- Analyst Decision
- SGRP
- PPCB
- Analyst Count
- SGRP 0
- PPCB 0
- Target Price
- SGRP N/A
- PPCB N/A
- AVG Volume (30 Days)
- SGRP 34.2K
- PPCB 341.9K
- Earning Date
- SGRP 11-13-2025
- PPCB 09-30-2025
- Dividend Yield
- SGRP N/A
- PPCB N/A
- EPS Growth
- SGRP N/A
- PPCB N/A
- EPS
- SGRP N/A
- PPCB N/A
- Revenue
- SGRP $143,501,000.00
- PPCB N/A
- Revenue This Year
- SGRP $7.22
- PPCB N/A
- Revenue Next Year
- SGRP N/A
- PPCB N/A
- P/E Ratio
- SGRP N/A
- PPCB N/A
- Revenue Growth
- SGRP N/A
- PPCB N/A
- 52 Week Low
- SGRP $0.91
- PPCB $1.25
- 52 Week High
- SGRP $2.48
- PPCB $145.46
- Technical
- Relative Strength Index (RSI)
- SGRP 49.90
- PPCB N/A
- Support Level
- SGRP $1.02
- PPCB N/A
- Resistance Level
- SGRP $1.08
- PPCB N/A
- Average True Range (ATR)
- SGRP 0.03
- PPCB 0.00
- MACD
- SGRP 0.01
- PPCB 0.00
- Stochastic Oscillator
- SGRP 73.33
- PPCB 0.00
About SGRP SPAR Group Inc.
SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. It also provides a range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from the Americas.
About PPCB Propanc Biopharma Inc.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.